Australia just made world headlines — but not in the way you’d think. The NSW Government and US biotech firm Tiba Biotech have unveiled the planet’s first mRNA vaccine for foot-and-mouth disease, a highly contagious virus in cattle and sheep. On paper, it’s a biosecurity masterstroke: protect an $80 billion meat industry from collapse if the disease ever jumps our borders. But here’s the kicker: no one asked consumers if they wanted a new generation of biotech running through their steak knives. No consultation. No label. No choice.
The government’s line is simple — this is about protecting exports, keeping supermarkets stocked, and shielding farmers from a catastrophic outbreak. NSW Agriculture Minister Tara Moriarty called it a “critical safeguard” against a disease that could devastate rural economies. Meat & Livestock Australia co-funded the project, cheering it as a fast-tracked insurance policy. And in German trials run by the Friedrich Loeffler Institute, vaccinated animals didn’t shed virus and showed no symptoms. A clean win for science.
Who's Behind It
-
Tara Moriarty – NSW Minister for Agriculture and Western NSW, leading the government’s biosecurity announcement and framing the vaccine as a strategic safeguard.
-
Andrew Ferguson – representing Meat & Livestock Australia, the industry body co-funding the project and guarding export viability.
-
Peter Kirkland – Virology Laboratory Manager at the NSW Department of Primary Industries (DPI), driving the scientific oversight of vaccine efficacy tests.
-
Peter McGrath – NSW DPI executive involved in coordinating research and rollout logistics.
-
Supporting Allies – Tiba Biotech (US) as the biotech innovator, the Friedrich Loeffler Institute in Germany for cattle trials data, and UNSW’s RNA Institute bolstering local manufacturing capacity.
Photo Credit: The Noticer- MIddle photo from left to right: Andrew Ferguson (Meat & Livestock Australia), Peter Kirkland (NSW DPI Virology Laboratory Manager), Tara Moriarty (NSW Minister for Agriculture and Western NSW), and Peter McGrath (NSW DPI), standing at the announcement of Australia’s first mRNA livestock vaccine.
But not everyone’s buying the hype. Sydney-based meat producer Stockman Steaks fired back, warning its customers that:
“mRNA vaccines represent a shift toward genetic interventions in our food supply. While hailed as innovative by some, questions linger about long-term effects on animal health, meat quality, and human consumption.”
That statement lit a match under an already smouldering debate. Social feeds are now flooded with “No consent”, “Boycott supermarkets”, and “Only buy direct from farmers.”
And that’s the bigger story here: trust. Conventional livestock vaccines — the kind that have been quietly protecting herds for decades — don’t spook shoppers. They use killed or weakened virus, they train immunity, and by the time meat hits your plate, nothing’s left but protein and fat. mRNA is different. It’s faster to make, doesn’t use live virus, and breaks down quickly in the body. But for consumers still scarred by COVID politics, “mRNA” sounds less like progress and more like an uninvited dinner guest.
And here’s the kicker: there have been no human food trials on meat from mRNA-vaccinated animals. Regulators like the APVMA assess safety based on animal studies and residue testing, not human consumption data. For many Australians, that’s the missing proof — and the reason labelling feels non-negotiable.
Tiba Biotech insists the tech is safe, storage-friendly, and tailor-made for agriculture. The vaccine, developed in just 18 months at a cost of $2.5 million, is part of a $20 million NSW project and now sits with the APVMA for approval. Officially it’s for “emergency use only,” but once greenlit, the infrastructure will be in place to roll it out nationwide at speed. And that’s why the debate over labelling matters. Because once the jab is in play, Australians won’t know if their lamb cutlets or Sunday roast came from an mRNA-vaccinated flock.
So let’s call it: this isn’t about meat science, it’s about consumer rights. If the government wants to inject livestock to protect exports, fine — but slapping a label on the end product is the bare minimum. Without transparency, trust evaporates. And in the food game, trust is harder to rebuild than any virus-free herd.
Frequently Asked Questions
What is Australia’s new mRNA livestock vaccine?
It’s the world’s first mRNA vaccine for foot-and-mouth disease in cattle and sheep, developed by Tiba Biotech with NSW Government backing.
Has this vaccine been tested for human consumption?
No. There are no human trials where people have eaten meat from vaccinated animals. Regulators assess safety through animal studies and residue testing, not direct human consumption data.
Will meat from vaccinated animals be labelled in Australia?
Currently, no. Food Standards Australia New Zealand (FSANZ) has not mandated labelling for livestock vaccinated with mRNA technology.
Why is this vaccine controversial?
Supporters say it’s about protecting an $80 billion livestock industry. Critics argue it’s a genetic intervention in the food supply without public consultation, raising questions around health sovereignty and informed choice.
When will the vaccine roll out?
The vaccine is still under review by the APVMA. It’s earmarked for “emergency use only” if foot-and-mouth disease breaches Australian borders.
Related Reads
-
Moderna Is Spraying Your Food: What They’re Not Telling You About RNA Agriculture
-
Serena Williams, Ozempic & the Family Business Behind the Hype
Article originally published: 3 September 2025, by Editor
